SEBI Reg. Investment Advisor

Download App

Help Center Pricing

Recent:

Top Pharma Companies in India by Market Cap

BSE Sensex 73983.18
64.42 (0.09%)

Filter

Top Pharma Companies in India as on Jun-2026 | 5 Star Rated Stocks Undervalued Stocks Fair Valued Stocks Uptrend Stocks

Filter

	Company Name	DeciZen	Market cap (Rs. Cr.)	CMP (Change %)	Latest P/E	Latest P/BV	5Y Sales Gr.(%)	5Y Profit Gr.(%)
61	Procter & Gamble Health Ltd.	Q V+ PT	10,325 Small Cap	6,256.35 (0.58%)	31.58	19.68	4.31	11.97	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
62	Healthcare Global Enterprises Ltd.	Q V+ PT	9,464 Small Cap	635.65 (0.28%)	649.08	5.9	13.15	0.00	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
63	Strides Pharma Science Ltd.	Q V+ PT	9,381 Small Cap	977.95 (-3.92%)	51.09	2.86	4.81	-16.98	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
64	Jupiter Life Line Hospitals Ltd.	Q V PT	8,763 Small Cap	1,312.05 (-1.83%)	45.79	5.45	18.02	36.61	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
65	Thyrocare Technologies Ltd.	Q V+ PT	8,721 Small Cap	532.50 (-2.82%)	53.37	15.07	10.88	8.62	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
66	Akums Drugs & Pharmaceuticals Ltd.	Q V PT	8,635 Small Cap	592.35 (7.97%)	77.34	3.56	12.22	23.36	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
67	Blue Jet Healthcare Ltd.	Q V PT	8,168 Small Cap	469.70 (-0.25%)	32.96	6.01	0.00	0.00	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
68	Yatharth Hospital & Trauma Care Services Ltd.	Q V PT	8,081 Small Cap	830.95 (-0.92%)	84.7	4.99	27.90	137.67	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
69	Supriya Lifescience Ltd.	Q V+ PT	7,744 Small Cap	952.45 (-1.01%)	37.03	6.47	17.45	18.30	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
70	Sanofi India Ltd.	Q V PT	7,263 Small Cap	3,176.45 (0.72%)	23.45	9.31	-8.74	-7.50	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
71	Nephrocare Health Services Ltd.	Q V+ PT	7,084 Small Cap	719.15 (1.86%)	N/A	7.3	0.00	0.00	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
72	Suven Life Sciences Ltd.	Q V+ PT	6,983 Small Cap	268.70 (1.47%)	N/A	4.65	-14.30	0.00	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
73	Sun Pharma Advanced Research Company Ltd.	Q V+ PT	6,792 Small Cap	205.80 (-1.67%)	4.38	5.09	-1.35	0.00	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
74	FDC Ltd.	Q V PT	6,416 Small Cap	381.15 (-3.29%)	22.44	2.57	9.23	1.32	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
75	Kovai Medical Center & Hospital Ltd.	Q V PT	6,290 Small Cap	5,846.30 (1.70%)	25.73	4.77	14.01	17.17	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
76	Aarti Pharmalabs Ltd.	Q V PT	5,659 Small Cap	621.55 (-0.43%)	32.12	2.85	0.00	0.00	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
77	Innova Captab Ltd.	Q V PT	5,254 Small Cap	907.65 (-1.15%)	62.78	5.93	25.90	14.68	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
78	Senores Pharmaceuticals Ltd.	Q V+ PT	5,037 Small Cap	1,111.95 (1.66%)	248.75	6.72	0.00	0.00	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
79	Bliss GVS Pharma Ltd.	Q V+ PT	4,449 Small Cap	423.70 (0.75%)	45.93	3.85	8.59	-5.52	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
80	Gujarat Themis Biosyn Ltd.	Q V+ PT	4,377 Small Cap	385.40 (-4.06%)	93.76	15.21	12.12	15.55	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
81	Orchid Pharma Ltd.	Q V PT	4,359 Small Cap	850.35 (-1.05%)	96.42	3.18	13.89	0.00	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
82	Advanced Enzyme Technologies Ltd.	Q V PT	4,166 Small Cap	373.05 (0.27%)	31.61	5.87	7.28	11.87	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
83	Artemis Medicare Services Ltd.	Q V PT	4,095 Small Cap	258.95 (0.12%)	39.58	4.71	10.15	32.48	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
84	IOL Chemicals And Pharmaceuticals Ltd.	Q V+ PT	3,901 Small Cap	129.45 (-2.60%)	28.34	2.17	0.00	0.00	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
85	Gufic Biosciences Ltd.	Q V PT	3,890 Small Cap	363.40 (-6.33%)	61.61	5.86	16.69	24.75	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
86	Panacea Biotec Ltd.	Q V+ PT	3,727 Small Cap	547.65 (-9.99%)	N/A	13.07	-8.75	0.00	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
87	Indraprastha Medical Corporation Ltd.	Q V+ PT	3,601 Small Cap	381.65 (-2.85%)	19.61	4.86	10.30	29.46	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
88	SMS Pharmaceuticals Ltd.	Q V+ PT	3,535 Small Cap	381.40 (1.05%)	40.35	4.39	13.70	14.47	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
89	RPG Life Sciences Ltd.	Q V+ PT	3,464 Small Cap	2,110.10 (0.76%)	30.07	5.72	11.71	30.85	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
90	Aarti Drugs Ltd.	Q V+ PT	3,443 Small Cap	371.80 (-1.43%)	17.66	2.22	5.74	4.42	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
Prev 1 2 3 4 5 Next

Screens:

AlphaCases Top Rated Stocks Best Nifty Stocks Best Nifty Next Stocks Best Nifty 500 Stocks Best SmallCap Stocks Top BFSI Stocks

Pharma - Today's Top Gainers

Company Name	CMP	Price Change(%)
Unichem Lab	439.40	16.23%
Akums Drugs & Pharma	592.35	7.97%
Kwality Pharma	2,509.15	7.40%
Concord Biotech	1,326.85	4.35%
3B Blackbio Dx	1,255	4%

Pharma - Today's Top Losers

Company Name	CMP	Price Change(%)
Panacea Biotec	547.65	-9.99%
Shree Ganesh Remed.	570.15	-7.59%
Gufic Biosciences	363.40	-6.33%
Park Medi World	279.80	-4.29%
Fermenta Biotech	327.50	-4.21%

News about Top Pharma Companies in India

Jun, 2026

Nephrocare Health Services informs about updates

Nephrocare Health Services has informed that Nephrocare Health Services, Philippines Inc., overseas step-down wholly owned subsidiary of the company has acquired a Dialysis centre and has executed Asset Transfer Agreement as per the disclosure annexed.

The above information is a part of company’s filings submitted to BSE.

Jun, 2026

Nephrocare Health shines as its arm inks asset transfer pact with Amica Healthcare System Corporation

The agreement is for the acquisition of identified assets relating to a dialysis center located at Dona Soledad, Don Bosco, Paranaque City, Philippines

Jun, 2026

Nephrocare Health’s arm inks asset transfer pact with Amica Healthcare System Corporation

The agreement is for the acquisition of identified assets relating to a dialysis center located at Dona Soledad, Don Bosco, Paranaque City, Philippines

Jun, 2026

Bliss GVS Pharma informs about open offer

Bliss GVS Pharma has informed that SBI Capital Markets (Manager to the Open Offer) has submitted a copy of Draft Letter of Offer to the Public Shareholders of Bliss GVS Pharma (Target Company).

The above information is a part of company’s filings submitted to BSE.

Jun, 2026

Gujarat Themis Biosyn informs about notice of postal ballot

Gujarat Themis Biosyn has informed that it enclosed a copy of the Notice of Postal Ballot of Gujarat Themis Biosyn (the Company) along with the Explanatory Statement pursuant to the applicable provisions of the Companies Act, 2013 read with the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, (Notice), seeking approval of the Members of the Company on the Resolution forming part of the Notice. In accordance with circulars issued by Ministry of Corporate Affairs (MCA), from time to time, this Notice is being sent only by electronic mode to the Members whose names appear on the Register of Members / list of Beneficial Owners as on Friday, 5th June, 2026 (cut-off date) and whose e-mail addresses are registered with the Company / Registrar and Transfer Agent (RTA) / Depositories. As per the provisions of the MCA Circulars, Members can vote only through the remote e-voting process. Company has engaged the services of the Central Depository Services (India) (CDSL) to provide remote e-voting facility. The voting rights shall be reckoned on the paid-up value of the shares registered in the names of the equity shareholders as on cut-off date. The procedure for remote e-voting is detailed in the Notes to the Notice.

The above information is a part of company’s filings submitted to BSE.

Jun, 2026

Advanced Enzyme gains on completing additional investment of Rs 25 lakh in ANPL

The investment will to be utilized by ANPL for its business and/or general corporate purposes

Top 10 Publicly Listed pharmaceutical stocks in India by Market Capitalization as of 2026.

Rank	Company	Market Capitalization 2026 (INR crores)
1	Sun Pharmaceutical Industries Ltd.	4,26,938 Crore
2	Divis Laboratories Ltd.	1,79,361 Crore
3	Torrent Pharmaceuticals Ltd.	1,51,385 Crore
4	Apollo Hospitals Enterprise Ltd.	1,22,585 Crore
5	Zydus Lifesciences Ltd.	1,11,264 Crore
6	Cipla Ltd.	1,11,220 Crore
7	Dr. Reddys Laboratories Ltd.	1,05,899 Crore
8	Lupin Ltd.	1,03,490 Crore
9	Mankind Pharma Ltd.	98,745 Crore
10	Max Healthcare Institute Ltd.	97,641 Crore

Do you know? Asking 3 Right Questions minimizes the RISK of Stock Investing To Know

Right Stock | Right Price | Right Allocation

Find best stocks to buy now Find best pharma stocks to buy now

Top 15 Pharma Stocks by Revenue Growth

Top Pharma Companies Source: NSE Indices

You can use different criterias to arrive at the list of best stocks in the Nifty Pharma company index. You can use return ratios like ROCE or ROE, that will help you choose companies with profitable growth.

Based on ROE, the best stocks in the Nifty Pharma companies index are:

Company Name	Is it a Right Stock ?	CMP	Market Cap(Cr.)	P/E	P/BV	EV/EBITDA	ROE
Abbott India Ltd. (M)	Very Good	26,479	55,558	35.80	11.64	24.45	35.71
Torrent Pharmaceuticals Ltd. (L)	Very Good	4,463	1,51,385	69.98	18.05	36.96	29.04
Ajanta Pharma Ltd. (M)	Very Good	3,073	37,632	35.64	8.31	24.09	24.45
Lupin Ltd. (M)	Somewhat Good	2,249	1,03,490	19.41	4.61	11.23	20.83
Zydus Lifesciences Ltd. (M)	Very Good	1,098	1,11,264	22.08	4.10	13.54	20.74

Based on the past year's gain, the best performing stocks are:

Company Name	Is it a Right Stock ?	CMP	Market Cap(Cr.)	Yearly gain (%)
Laurus Labs Ltd. (M)	Very Good	1,385	76,956	114
Torrent Pharmaceuticals Ltd. (L)	Very Good	4,463	1,51,385	40.69
Gland Pharma Ltd. (S)	Very Good	2,268	37,741	38.82
Glenmark Pharmaceuticals Ltd. (M)	Very Good	2,144	62,289	38.09
JB Chemicals & Pharmaceuticals Ltd. (S)	Very Good	2,204	35,481	31.79
				View More

Stocks with the highest revenue growth in the past 5 years is:

Company Name	Is it a Right Stock ?	CMP	Market Cap(Cr.)	P/E	P/BV	EV/EBITDA	5Y Sales Growth (%)
JB Chemicals & Pharmaceuticals Ltd. (S)	Very Good	2,204	35,481	52.63	8.79	31.88	15.51
Mankind Pharma Ltd. (M)	Very Good	2,372	98,745	48.46	6.02	30.50	14.65
Dr. Reddys Laboratories Ltd. (M)	Very Good	1,272	1,05,899	25.24	2.79	13.93	13.26
Ajanta Pharma Ltd. (M)	Very Good	3,073	37,632	35.64	8.31	24.09	12.43
Torrent Pharmaceuticals Ltd. (L)	Very Good	4,463	1,51,385	69.98	18.05	36.96	11.80

Stocks with high profit growth often witness their stock prices gaining, irrespective of the market movements.

Stocks with the highest profit growth in the past 5 years is:

Company Name	Is it a Right Stock ?	CMP	Market Cap(Cr.)	P/E	P/BV	EV/EBITDA	5Y Profit Growth (%)
Zydus Lifesciences Ltd. (M)	Very Good	1,098	1,11,264	22.08	4.10	13.54	30.57
Sun Pharmaceutical Industries Ltd. (L)	Very Good	1,787	4,26,938	37.19	5.11	21.29	23.50
Dr. Reddys Laboratories Ltd. (M)	Very Good	1,272	1,05,899	25.24	2.79	13.93	22.29
Abbott India Ltd. (M)	Very Good	26,479	55,558	35.80	11.64	24.45	18.78
Ajanta Pharma Ltd. (M)	Very Good	3,073	37,632	35.64	8.31	24.09	17.07

You have 2 views remaining as a Guest User. To get DeciZen Rating of 3,500+ Stocks based on their Quality, Valuation and Price Trend Login | Register Now

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Fiduciary-first advisory model.
As SEBI-registered IAs, we are legally and ethically bound to act in the best interests of our clients. We do not sell or distribute any financial products. This ensures our guidance is 100% unbiased and conflict-free.
Deep fundamental research + robust valuation discipline.
Built on more than 15 years of equity research, our framework combines quality assessment, intrinsic value estimation, and a sensible margin-of-safety approach.
Process—not predictions.
We don’t rely on guesswork or market timing. Instead, we focus on asset allocation, risk management, and long-term compounding.
Technology + Human Intelligence.
We believe a combination of both is essential for investing success. We constantly innovate and upgrade in-house tools, financial X-rays, and portfolio analytics so that our team of analysts and advisors are equipped with the best.
Partner with Clients.
We follow a DIWM (Do-It-With-Me) approach where we partner clients in setting goals, financial planning, educating on our investing process and share decision-enabling resources transparently with our clients who retain control on execution.

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

Investing in stocks, mutual funds, debt, and gold
Quality-at-Reasonable-Price way of investing in stocks
Constructing Direct Stock Portfolios with Core, Booster, and Amplifier stocks
A Mutual Fund Portfolio that delivers consistent out-performance and meaningful diversification (low overlap)
Periodic review and rebalancing
Clear Buy-Sell-Hold, and Position-sizing frameworks

Name of the IA registered with SEBI:	The Alchemists Ark Pvt. Ltd.
Logo:
Trade/Brand Name of IA:	MoneyWorks4Me Investment Advisers
Brand Logo:
SEBI Registration Number:	INA000013323 Validity – May 16, 2019 – Perpetual
Registration:	Non-Individual
BSE Enlistment No:	1187
Address:	B-101, Signet Corner Building, Balewadi Phata, Baner, Pune, Maharashtra 411045
Compliance officer Details:	Name: Shrikant Jagtap Email: shrikant.jagtap@moneyworks4me.com Telephone: +919860359463 Address: Same as IA
Grievance Officer Details:	Name: Mukta Vaze Email: mukta.vaze@moneyworks4me.com Telephone: +91 98609 19463 Address: Same as IA
Principal Officer Details:	Name: Atharva Bhide Email: atharva.bhide@moneyworks4me.com Telephone: +91 91758 99463 Address: Same as IA
Standard Warning:	Investment in securities market are subject to market risks. Read all the related documents carefully before investing.
Disclaimer:	Registration granted by SEBI, enlistment with exchange and certification from NISM in no way guarantee performance of the intermediary or provide any assurance of returns to investors.

Top Pharma Companies in India by Market Cap

News about Top Pharma Companies in India

Nephrocare Health Services informs about updates

Nephrocare Health shines as its arm inks asset transfer pact with Amica Healthcare System Corporation

Nephrocare Health’s arm inks asset transfer pact with Amica Healthcare System Corporation

Bliss GVS Pharma informs about open offer

Gujarat Themis Biosyn informs about notice of postal ballot

Advanced Enzyme gains on completing additional investment of Rs 25 lakh in ANPL

Publicly traded pharmaceuticals

Top 10 Publicly Listed pharmaceutical stocks in India by Market Capitalization as of 2026.

Top 15 Pharma Stocks by Revenue Growth

Top Pharma Companies Source: NSE Indices

How to select the top Nifty Pharma stocks based on RoE?

What are the best-performing stocks in the Nifty Pharma index?

Which Nifty Pharma stocks have the highest revenue growth in the past five years?

Which Nifty Pharma stocks had the highest profit growth in the past five years ?

About MoneyWorks4Me

Our Vision

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.